drugset / Trial / NCT03444519

The Therapeutic Time Window of Mannitol During Craniotomy for Optimal Brain Relaxation in Patients With Supratentorial Tumours

NCT03444519

Completed 100 enrolled Huashan Hospital
RandomizedParallel-groupDouble-blindOther

Summary

Although mannitol is used for brain relaxation during neurosurgery and in the treatment of raised intracranial pressure; there is not a consensus on its safe, effective dose and the duration of its administration. This study aimed to compare the effects of the mannitol in different use times, on the brain relaxation, electrolyte, lactate levels of the blood, peroperative fluid balance and the volume of the urine in supratentorial mass resection surgeries.

Timeline

Start
2018-03-01
Primary completion
2019-03-14
Completion
2019-04-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Mannitol Diagnostic / imaging agent 1 g/kg

Indications